NCT06846112Active, not recruiting
Randomized Clinical Trial Aimed at Comparing Unclamped Robotic Partial Nephrectomy With or Without Renorrhaphy
Randomized Clinical Trial Aimed at Comparing Unclamped Robotic Partial Nephrectomy With or Without Renorrhaphy. Randomized Control Trial Comparing Off-clamp Robotic Partial Nephrectomy With or Without Renorrhaphy. Project: GR-2021-12373396
Source: ClinicalTrials.gov · Last updated 17 Dec 2025
Brief summary (registry, in English)
Intended to minimize ischemia during robotic partial nephrectomy (RPN) procedures "by any means possible". Before starting enucleation, the boundaries of the tumor are marked during SL-ocRPN surgery cautery. Once the tumor is removed, the resection bed is cauterized by dispensing monopolar energy with "quasi-contact" mode, and hemostasis is progressively improved.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 248 (estimated)
- First submitted
- 6 Mar 2024
- Start date
- 7 Jul 2023
- Primary completion date
- 7 Jul 2028
- Lead sponsor
- Regina Elena Cancer Institute
- Diseases
- Kidney cancer
- NCT number
- NCT06846112
What you commit to
- Study type: Interventional
- Planned participants: 248
- From 7 Jul 2023 to the primary completion date, 7 Jul 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- personal history of renal surgery for benign or malignant pathology.
Other
- preoperative evidence of unilateral/bilateral synchronous renal neoplasms;
Who the study is looking for
- age ≥ 18 years;
- radiological diagnosis of organ-confined renal neoplasm (cT1-2 cN0);
- patient who is a candidate, due to personal or tumor characteristics, for ocRPN intervention;
- compliant patient, able to follow the procedures/follow-up;
- patient who agrees to participate in the clinical study and the planned randomization, by signing the informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Regina Elena National Cancer Institute Coordinator of this site? Confirm its status | Rome | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.